Long-term survival and quality of life in patients more than 10 years after pelvic exenteration - Scorecard - MDSpire

Long-term survival and quality of life in patients more than 10 years after pelvic exenteration

  • By

  • Daniel Steffens

  • Michael J Solomon

  • Sascha Karunaratne

  • Kilian Brown

  • Bora Kim

  • Peter Lee

  • Kirk Austin

  • Christopher Byrne

  • Lilian Whitehead

  • Cherry Koh

  • June 12, 2025

  • 0 min

Share

Clinical Scorecard: Survival Rates and Quality of Life Assessment in Patients Over a Decade Post-Pelvic Exenteration

At a Glance

CategoryDetail
ConditionAdvanced primary or recurrent pelvic malignancies
Key MechanismsRadical surgical removal of pelvic organs aiming for complete oncological clearance (R0 resection)
Target PopulationSelected patients with advanced or recurrent pelvic cancer suitable for pelvic exenteration
Care SettingSpecialized multidisciplinary surgical centers

Key Highlights

  • One-third of patients survive beyond 10 years post-pelvic exenteration with median overall survival of 4.8 years.
  • Quality of life improves steadily within 18 months post-surgery and remains stable, with mental and physical health scores approaching population norms.
  • Pelvic exenteration involves substantial morbidity and prolonged recovery but offers curative potential in selected patients.

Guideline-Based Recommendations

Diagnosis

  • Patient selection via multidisciplinary team assessment including clinical, histopathological, and radiological evaluation.
  • Ensure absence of unresectable distant metastatic disease and feasibility of complete oncological clearance.

Management

  • Perform pelvic exenteration in specialized centers with experienced multidisciplinary teams.
  • Provide extensive preoperative counseling on risks, benefits, and alternatives to radical surgery.
  • Plan for prolonged recovery involving rehabilitation and management of permanent stomas and functional changes.

Monitoring & Follow-up

  • Long-term follow-up beyond 10 years to assess survival and quality of life.
  • Use validated patient-reported outcome measures such as SF-36v2 and FACT-C questionnaires at multiple time points.
  • Systematic verification of survival status through medical records and clinical team consultation.

Risks

  • High morbidity rates including impacts on body image, sexual function, and daily activities.
  • Potential for postoperative mortality and multiple readmissions during recovery.

Patient & Prescribing Data

Patients undergoing pelvic exenteration for advanced or recurrent pelvic malignancies at a tertiary referral center

Survival rates at 5, 10, and 15 years post-surgery are approximately 48.4%, 35.1%, and 31.5% respectively; quality of life stabilizes after initial improvement and aligns with population norms in several domains.

Clinical Best Practices

  • Adopt a multidisciplinary team approach for patient selection and surgical planning.
  • Provide thorough preoperative counseling addressing expected morbidity and quality-of-life impacts.
  • Implement long-term quality-of-life assessments using validated instruments.
  • Manage postoperative recovery with multidisciplinary rehabilitation and support services.
  • Maintain specialized surgical expertise and infrastructure to optimize outcomes.

References

Original Source(s)

Related Content